Alpha DNA Investment Management’s TD Synnex SNX Stock Holding History

Alpha DNA Investment Management’s Portfolio SNX Stock Details SNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-10	Closed	–	–	769
2020 Q4	$0	Buy	+10	New	+$764	﹤0.01%	627

Other funds holding SNX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

ABI

Abrams Bison Investments Bethesda, Maryland $2.05B AUM 71.03% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

LAM

Lyrical Asset Management New York $7.88B AUM 36.5% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

BAM

Burgundy Asset Management Toronto, Ontario, Canada $10.6B AUM 13.39% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Alpha DNA Investment Management's SNX Position: Q1 2021 in Review

Alpha DNA Investment Management sold out of TD Synnex (SNX) in Q1 2021, closing a stake of 10 shares.

Alpha DNA Investment Management first reported a position in SNX in Q4 2020 and held it in 1 quarter. The position peaked at $0 in Q4 2020. 332 funds tracked by Wall St. Rank hold SNX as of Q1 2021.

Alpha DNA Investment Management reported no remaining TD Synnex position as of Q1 2021 after selling out during the quarter.
Alpha DNA Investment Management sold 10 TD Synnex shares in Q1 2021.
Alpha DNA Investment Management first reported a position in TD Synnex in Q4 2020 and held it in 1 quarter.
Alpha DNA Investment Management's TD Synnex position peaked at $0 in Q4 2020.
332 funds tracked by Wall St. Rank held TD Synnex as of Q1 2021.

Based on Alpha DNA Investment Management's 13F filing for Q1 2021, filed 12 May 2021.